Lavistina Tablet
Betahistine Dihydrochloride
8mg
TABUK PHARMACEUTICAL MANUFACTURING CO
| Pack size | 100's (10's Blister x 10) |
|---|---|
| Dispensing mode | POM |
| Source | SAUDI ARABIA |
| Agent | AL PHAMED CO.ABUDHABI LTD.LLC |
| Retail Price | 40.00 AED |
Available as:
Indications
Lavistina Tablet is used for:
Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.
Adult Dose
Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.
Child Dose
Renal Dose
Administration
Should be taken with food.
Contra Indications
Phaeochromocytoma. Porphyria.
Precautions
Active peptic ulcer, bronchial asthma, pregnancy and lactation.
Pregnancy-Lactation
Interactions
May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.
Adverse Effects
Side effects of Betahistine Dihydrochloride :
Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.
Mechanism of Action
Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.
Note
Lavistina 8mg Tablet manufactured by TABUK PHARMACEUTICAL MANUFACTURING CO. Its generic name is Betahistine Dihydrochloride. Lavistina is availble in United Arab Emirates.
Farmaco UAE drug index information on Lavistina Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.